Enoxaparin is the generic name of Clexane®/Lovenox®, a low molecular weight heparin manufactured by Sanofi-Aventis. more...
Enoxaparin is indicated for use in both treatment and prophylaxis settings which means it can be used in many therapy areas by a wide range of specialists.
Enoxaparin is used to prevent and treat thromboembolic diseases, and is usually administered by injection by either GP, nurse or the patient themself.
In the UK, enoxaparin is approved for five indications:
- The prophylaxis of thromboembolism disorders of venous origin, in particular those which may be associated with orthopaedic surgery.
- The prophylaxis of venous thromboembolism (VTE) in medical patients bedridden due to acute illness.
- The treatment of venous thromboembolism disease (VTED) presenting with deep vein thrombosis (DVT), pulmonary embolism (PE) or both.
- The treatment of unstable angina (UA) and non-Q-wave myocardial infarction (NQMI), administered concurrently with aspirin.
- The prevention of thrombus formation in the extracorpreal circulation during haemodialysis.
- Pain, bruising or irritation; hard, inflamed nodules or an itchy red rash at the injection site
- Symptoms similar to those of hayfever
- Abdominal/chest pain
Read more at Wikipedia.org